Art Therapy for Enhancing Well-Being in Solitary Older Adults
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorNational Taiwan University Hospital
About this trial
This study explores the impact of art therapy on mental health and quality of life among solitary older adults. Participants will be randomly assigned to one of two groups: an experimental group receiving art therapy sessions or a control group with no intervention. The art therapy program includes 12 weekly sessions lasting 90 minutes each, focusing on creative expression, observation of art, and reflective discussions. These activities are designed to enhance emotional well-being, reduce depressive symptoms, and foster interpersonal connections.
Both groups will undergo evaluations before and after the 12-week study period. The assessments will include the Taiwanese version of the WHO Quality of Life-BREF (WHOQOL-BREF) and the Beck Depression Inventory (BDI) to measure changes in psychological health and life satisfaction. The findings aim to demonstrate the feasibility and benefits of art therapy as a non-pharmacological intervention for improving the well-being of solitary older adults.
Eligibility criteria
Qualifiers
Age 65 years or older.
Living alone.
Mini-Mental State Examination (MMSE) score between 24 and 30, indicating no significant cognitive impairment.
Capable of providing informed consent.
Disqualifiers
Recent major life events (e.g., bereavement, severe illness) that could interfere with study participation.
History of brain injury or severe psychiatric conditions, such as schizophrenia or major depressive disorder requiring hospitalization.
Physical disabilities or motor impairments that prevent participation in art activities.
Participation in similar art therapy studies within the past 6 months.
Trial design
Treatments tested in this trial
- Art Therapy Program
Treatment groups
22 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
National Taiwan University Hospital
Lead sponsor
National Yunlin University of Science and Technology
Collaborator
Source ClinicalTrials.gov